Results 121 to 130 of about 1,622,247 (397)

ELECTROPHYSIOLOGY: Temporary cardiac pacing [PDF]

open access: yesHeart, 2000
Paul Zoll first applied clinically effective temporary cardiac pacing in 1952 using a pulsating current applied through two electrodes attached via hypodermic needles to the chest wall in two patients with ventricular standstill.1 Although this technique was uncomfortable for the patients it was effective for 25 minutes in one patient and nearly five ...
openaire   +3 more sources

Ventricular Tachycardia in the Absence of Structural Heart Disease [PDF]

open access: yes, 2005
In up to 10% of patients who present with ventricular tachycardia (VT), obvious structural heart disease is not identified. In such patients, causes of ventricular arrhythmia include right ventricular outflow tract (RVOT) VT, extrasystoles, idiopathic ...
Appleton, Christopher P   +4 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

How to diagnose and manage patients with cardiac implantable electronic device infections

open access: yesJournal of Arrhythmia, 2013
Over the last two decades, there has been a surge in the number of Cardiac Implantable Electronic Device (CIED) implantation. These devices improve the quality of life and survival among certain cardiac patients.
Khaldoun G. Tarakji, Bruce L. Wilkoff
doaj   +1 more source

A new era of physiologic cardiac pacing. [PDF]

open access: yesEur Heart J Suppl, 2023
Burri H, Vijayaraman P.
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Electroanatomic mapping reconstruction with photogrammetry across different mapping systems

open access: yesFrontiers in Imaging
BackgroundAutomatic digital photogrammetry produces digital reproductions of objects using photographs. The aim of this study is to analyze feasibility of photogrammetry for electroanatomic map (EAM) reconstruction from different mapping systems ...
Giacomo Talevi   +15 more
doaj   +1 more source

The essentials of cardiac pacing [PDF]

open access: green, 1978
G Fontaine   +3 more
openalex   +1 more source

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]

open access: yes, 2005
Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Francis, Johnson   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy